November 10th, 2026High Triglycerides Independently Linked with Severe COVID-19 DeathInvestigators believe triglyceride testing could improve viral sepsis risk more broadly based on study findings.Read more
November 10th, 2026Q&A: Antiretroviral Formulary Protocol Cuts Costs, Eases WorkflowNicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, explains how education eases inpatient switches, and how the protocol cuts costs and simplifies workflow.Read more
November 10th, 2026FDA Adds NAION Eye Risk Warning to All GLP-1 LabelsFindings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.Read more
November 9th, 2026FDA Grants Tentative Approval for First Generic LenacapavirGilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.Read more
November 9th, 2026ACCESS to Pharmacy Care Model Lets Pharmacists Bill for Chronic CareMark Ey, RPh, from NCPA, joins to discuss the opportunities for independent pharmacies within the ACCESS to Pharmacy Care Program.Read more
November 7th, 2026US Lost Over 3000 Pharmacies From 2022 to 2024, Mostly ChainsResearchers say this net loss is unlikely to reverse without state and federal policy changes, including PBM reform.Read more
November 6th, 2026Missouri Challenges Lilly’s 340B Data Policy: What Stakeholders Should KnowAt the center of the debate are the growing number of manufacturer demands for claims data as a condition of 340B pricing. Read more
November 6th, 2026How Pharmacist-Led ART Protocol Improves HIV Medication OutcomesNicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, discusses his team’s and patients’ experiences in a pharmacist-led antiretroviral initiative.Read more